Date: January 13, 2017 @ 6:00 pm – @ 8:30 pm
Location: Room 130 Li Kai Shing Center, Stanford University (291 Campus Drive, Palo Alto, CA 94305)
BGI 2017 International Talent Acquisition Program – Silicon Valley Info Session
(and business development opportunity)
华大基因2017国际人才招聘计划 – 硅谷宣讲会
Please register at your earliest convenience. Registration is free.
6:00 pm - 6:20 pm Networking
6:20 pm - 6:30 pm Introduction and welcome by CABS
6:30 pm - 7:00 pm Business Landscape and Career Development at BGI, by Ye Yin, Ph.D., CEO of BGI Genomics
7:00 pm - 7:30 pm R&D and Global Talent Demand at BGI, by Xun Xu, Ph.D., Director, BGI Research, Executive Director, China National GeneBank
7:30 pm - 7:45 pm BGI's Journey of Globalization, by Ning Li, Ph.D., Chief Development Officer, BGI Genomics
7:45 pm - 8:15 pm Panel Discussion
8:15 pm - 8:30 pm Networking
The executive team of BGI (formerly known as Beijing Genomics Institute) will be joining CABS and ACSSS for recruitment and information session at Stanford LK130 on Jan 13, 2017. The delegation consists of Dr. Ye Yin, the CEO of BGI Genomics, Dr. Xun Xu, Executive Director of BGI Research and the Chinese National GeneBank, Dr. Ning Li, Chief Development Officer of BGI Genomics. They will give a high profile overview of BGI’s history and vision in global health, the current R&D and business scope both in China and the international space as well as their personal career path with the growth of BGI. This event also serves as a kick-off of BGI’s 2017 global talent recruitment program in the US. We welcome any interested parties and individuals to join the event and to discuss career/business opportunities brought from BGI.
BGI 2017 International Talent Acquisition Program
Job location: US: Mountain View, Boston, Philadelphia; China: Shenzhen, Hong Kong, Tianjin, Wuhan
Job Level: Senior Individual Contributor, Director level
Job Function: R&D, Product Development, Business Development
The detailed job descriptions will be send out before the info session. Stayed tuned!
Ye Yin. Ph.D.
CEO, BGI Genomics Co. Ltd.
Dr. Ye Yin, serves as Chief Executive Officer of BGI Genomics Co., Ltd. He leads his team providing total genomics solution to top medical centers, global pharmaceutical companies and institutions. Ye has rich experience in global business management, international collaboration and lab production management. He was the crucial contributor to SARS diagnosis in 2003 and also a key member of “1000 Plant and Animal Reference Genomes”. He has published over 50 scientific papers on most prestigious academic journals like Nature, Science and PNAS, etc. Ye actively involves in lots of non profit organizations to help fund HLA and other rare disorder diseases.
Xun Xu, Ph.D.
Director, BGI Research, Executive Director, China National GeneBank.
Dr. Xun Xu serves as Director of BGI-Research and Executive Director of China National GeneBank (CNGB). He leads the technology development in the area of molecular biology, information technology, assembly and evolution of plants and animals, plant and animal genetic polymorphism, animal and plant molecular breeding, single cell sequencing platform, microchip-based DNA synthesis technology and synthetic genomics. He led a team of BGI Research to successfully develop the sequencer, BGISEQ-500, which is now the only commercial sequencing platform designed and made in China. In addition to sequencing technologies, he also led the cutting-edge experimental and bioinformatics developing at BGI. He has published 139 papers in high impact international journals and holds over 50 patents. He was awarded the youngest Senior Researcher in Natural Science and Technology of Hubei Province in 2013, the “National Leading Talent” in Shenzhen City in 2014 and the "Grand Challenge Young Scientists" by the Chinese Ministry of Science and Technology and Bill & Melinda Gates Foundation in 2015.
Ning Li, Ph.D.
Chief Development Officer, BGI Genomics Co. Ltd.
Dr. Ning Li currently serves as the Chief Development Officer at BGI Genomics Co. Ltd., responsible for BGI’s international business as well as its global development on BGI community of precision medicine. He was the CEO of BGI Europe from 2011-2015 and has led this BGI subsidiary from 5 employees to over 100 today by successfully forming key business partnerships and scientific collaborations with private and public institutions across Europe. Prior to that, Dr. Li led a research group within BGI Shenzhen, which successfully developed NGS-based epigenomics platforms and bioinformatics analysis tools specifically for epigenome data analysis. He received his Ph.D. in Bioinformatics at Beijing Institute of Genomics of the Chinese Academy of Science in 2010, and his Bachelor of Physics from Nankai University in 2004.
BGI was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI’s distinguished achievements have made a significant contribution to the development of genomics throughout the world. BGI also offers a wide portfolio of transformative genetic testing products across major diseases, enabling medical providers and patients worldwide to realize the promise of genomics-based diagnostics and personalized healthcare. BGI’s services and solutions are available in more than 62 countries around the world.
Headquartered in Shenzhen, BGI started international operations in 2009 and now has a global presence throughout the Americas, Europe, and Asia-Pacific, and includes both non-profit and for-profit parts. BGI has established 47 labs (including joint labs) globally. While its largest international laboratory is in Hong Kong, BGI also has major facilities in Copenhagen, Denmark; Mountain View, California, and Philadelphia, Pennsylvania. BGI has over 5000 employees worldwide.
- BGI (华大基因)
- CABS (Chinese American Biopharmaceutical Society)
- ACSSS (Association of Chinese Students and Scholars at Stanford)
Co-organizers and medium support:
- CBA (Chinese Biopharmaceutical Association)
- ACSS at UCSF (Association of Chinese Students and Scholars at UCSF)
- CASPA (Chinese American Semiconductor Professional Association)
- CGPSA (Chinese Graduate and Postdoctoral Scholars Association at UC Berkeley)
Recommended Parking Garage: Pasteur Visitor Garage A (200 Pasteur Dr)
Frank Hu, Ph.D.
Business Development Manager – Bay Area
BGI Americas Corp.
Yan Wang, Ph.D.
Committee Chair – CABS Allance Management